以往，临床对肺性脑病多采用在低流量吸氧等常规综合治疗的基础上加用传统的肺脑合剂静脉滴注或进行机械通气治疗，但病死率仍达４０％～６０％。１９９４～１９９６年，我们将传统的肺脑合剂进行了改良，并用于２８例肺性脑病患者，取得满意效果，现报告如下。临床资料：本文 In the past, the clinical use of pulmonary encephalopathy in the low flow of oxygen and other conventional comprehensive treatment based on the use of traditional pulmonary brain mixture intravenous infusion or mechanical ventilation, but the mortality rate is still up to 40% to 60%. From 1994 to 1996, we improved the traditional lung-lung mixture and applied it to 28 patients with pulmonary encephalopathy and achieved satisfactory results. The report is as follows. Clinical data: This article